Leukadherin-1
Leukadherin-1, a specific agonist of the leukocyte surface integrin CD11b/CD18, increases CD11b/CD18-dependent cell adhesion to fibrinogen with an EC50 of 4 μM. Leukadherin-1 enhances leukocyte adhesion to ligands (such as ICAM-1) and vascular endothelium and thus reduces leukocyte transendothelial migration and influx to the injury sites. Leukadherin-1 suppresses innate inflammatory signaling[1][2][3].
Product Specifications
CAS Number
344897-95-6
UNSPSC
12352005
Hazard Statement
H302, H410
Target
Complement System; Integrin
Type
Reference compound
Related Pathways
Cytoskeleton; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Leukadherin-1.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=C(C2=CC=C(/C=C(SC(N3CC4=CC=CC=C4)=S)/C3=O)O2)C=C1
Molecular Formula
C22H15NO4S2
Molecular Weight
421.49
Precautions
H302, H410
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human PDGF-AA Recombinant Rabbit monoclonal Antibody
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, 0.1mg/mL
BPY2 (BPY2C) (NM_001002761) Human Over-expression Lysate
